Congenital Adrenal Hyperplasia industry by Latest Therapeutic Developments, Rising Demand and Trend Analysis
Congenital Adrenal Hyperplasia industry Congenital adrenal hyperplasia is an inherited genetic disorder affects the adrenal glands. The patient suffering from these disorders lacks CAH enzymes which help in the production of hormones that help regulate metabolism, the immune system, blood pressure and other essential physiological functions. These disorders most commonly occur in children and infants. A number of the diagnostic tests are available in the market for the diagnosis of these disorders. According to the National Institute of Child Health and Human Development (2015), about one in 18,000 children suffer from congenital adrenal hyperplasia each year. The global Congenital Adrenal Hyperplasia industry is majorly driven by the increasing prevalence of the disorder, unmet needs for the treatment of the genetic disorders and rising demand for better and effective medicines for the treatment. The risk of these disorders increases in the patients with the history of ...